Growth Metrics

Outlook Therapeutics (OTLK) Preferred Shares (2017 - 2018)

Outlook Therapeutics (OTLK) has disclosed Preferred Shares for 3 consecutive years, with $2.7 million as the latest value for Q1 2018.